Central Pharmaceuticals Ltd. (DSE:CENTRALPHL)

Central Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 5, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	1,030	1,246	2,168	1,486	1,569	1,581
Market Cap Growth	-29.51%	-42.54%	45.97%	-5.34%	-0.76%	-0.75%
Enterprise Value	1,298	1,513	2,454	1,752	1,818	1,803
Last Close Price	8.60	10.40	18.10	12.40	13.10	13.20
PS Ratio	29.90	37.69	73.26	50.65	60.37	10.67
PB Ratio	1.28	1.51	2.57	2.22	2.20	2.02
P/TBV Ratio	1.28	1.51	2.57	2.22	2.20	2.02
P/FCF Ratio	-	-	731.27	-	-	-
P/OCF Ratio	32960.75	-	731.27	-	-	880.40
EV/Sales Ratio	37.66	45.77	82.90	59.75	69.92	12.17
EV/EBITDA Ratio	-	-	-	-	-	45.42
EV/EBIT Ratio	-	-	-	-	-	264.59
EV/FCF Ratio	-	-	827.53	-	-	-
Debt / Equity Ratio	0.33	0.33	0.32	0.40	0.38	0.32
Debt / EBITDA Ratio	517.17	-	-	-	-	6.33
Debt / FCF Ratio	8588.99	-	90.64	-	-	-
Net Debt / Equity Ratio	0.33	0.33	0.32	0.40	0.37	0.32
Net Debt / EBITDA Ratio	514.79	-246.49	-11.01	-12.66	-11.31	6.26
Net Debt / FCF Ratio	8549.42	-515.45	90.05	-819.93	-238.46	-52.00
Asset Turnover	-	0.02	0.02	0.02	0.02	0.11
Inventory Turnover	-	2.22	2.55	1.90	1.26	2.06
Quick Ratio	0.20	0.20	0.23	0.25	0.25	0.26
Current Ratio	1.08	1.10	1.14	1.18	1.25	1.37
Return on Equity (ROE)	-	-2.63%	-5.60%	-6.35%	-9.12%	-1.08%
Return on Assets (ROA)	-	-0.99%	-1.74%	-2.32%	-2.49%	0.31%
Return on Invested Capital (ROIC)	-1.91%	-2.06%	-3.68%	-4.99%	-5.30%	0.67%
Return on Capital Employed (ROCE)	-1.90%	-2.10%	-3.40%	-5.10%	-5.40%	0.60%
Earnings Yield	-1.84%	-1.76%	-1.96%	-2.96%	-4.35%	-0.54%
FCF Yield	-	-0.04%	0.14%	-0.02%	-0.07%	-0.30%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.